Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 405

    Novartis readies for FDA review of 1 billion dollar CAR-T child cancer hope

    Novartis readies for FDA review of 1 billion dollar CAR-T child cancer hope

    Ruby Khatun Khatun14 July 2017 9:20 AM IST
    ZURICH: Two decades ago in a Memphis, Tenn., hospital lab, cancer scientist Dario Campana and his team were hunting for a new way to fight deadly...
    Biocon advances over 8 per cent, seeks USFDA approval for breast cancer drug

    Biocon advances over 8 per cent, seeks USFDA approval for breast cancer drug

    Ruby Khatun Khatun13 July 2017 2:19 PM IST
    Mumbai: The stock of Biocon Ltd. surged over 8% in the early morning trade on Wednesday, on the BSE ahead of the USFDA meet to discuss its breast...
    USFDA issues warning letter to Hyderabad-based Vista Pharma

    USFDA issues warning letter to Hyderabad-based Vista Pharma

    Ruby Khatun Khatun13 July 2017 2:19 PM IST
    Hyderabad: The USFDA has issued a warning letter to the manufacturing facility of the city-based Vista Pharmaceuticals Ltd, for "significant...
    FDA lifts hold on Concert Pharmas study testing hair loss drug

    FDA lifts hold on Concert Pharma's study testing hair loss drug

    Ruby Khatun Khatun13 July 2017 9:58 AM IST
    Concert Pharmaceuticals Inc said on Monday the U.S. Food and Drug Administration (FDA) lifted a clinical hold on a trial testing its therapy for...
    Zydus Cadila gets USFDA nod to market anti-dementia tablets

    Zydus Cadila gets USFDA nod to market anti-dementia tablets

    Ruby Khatun Khatun13 July 2017 9:19 AM IST
    New Delhi: Zydus Cadila has received final approval from the US health regulator to market Memantine Hydrochloride tablets, used to treat dementia, in...
    Piramal to expand pharma vertical presence in US, Europe

    Piramal to expand pharma vertical presence in US, Europe

    Ruby Khatun Khatun12 July 2017 2:39 PM IST
    New Delhi: Piramal Enterprises has said it is looking to expand presence of its pharma vertical in global markets such as the US, Europe and Japan...
    Shire, Roche slug it out in billion-dollar haemophilia drug battle

    Shire, Roche slug it out in billion-dollar haemophilia drug battle

    Ruby Khatun Khatun12 July 2017 10:46 AM IST
    ZURICH: Swiss drugmaker Roche's bid to take a chunk of the $11 billion haemophilia drug market dominated by Shire took another blow with the Irish...
    Credihealth, Rubique tie-up to introduce collateral-free medical loan facility

    Credihealth, Rubique tie-up to introduce collateral-free medical loan facility

    Ruby Khatun Khatun12 July 2017 9:58 AM IST
    New Delhi: Medical assistance company Credihealth on Tuesday announced the launch of a medical loan facility on its platform.The company announced its...
    Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

    Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

    Ruby Khatun Khatun12 July 2017 9:46 AM IST
    DUBLIN: Medtronic plc announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM)...
    Suven Life Sciences gets NCEs patents from Israel, Macau and S Korea

    Suven Life Sciences gets NCEs patents from Israel, Macau and S Korea

    Ruby Khatun Khatun11 July 2017 2:22 PM IST
    New Delhi: Suven Life Sciences has received product patents from Israel, Macau and South Korea for New Chemical Entities (NCEs) used in the treatment...
    USFDA to lift import alert on Visakhapatnam unit: Divis Labs

    USFDA to lift import alert on Visakhapatnam unit: Divis Labs

    Ruby Khatun Khatun11 July 2017 10:09 AM IST
    New Delhi: Drug firm Divis Laboratories said US health regulator will lift an import alert imposed on the company's Unit-II at Visakhapatnam.The...
    Alembic Pharma receives USFDA Tentative Approval for Dabigatran Etexilate Capsules

    Alembic Pharma receives USFDA Tentative Approval for Dabigatran Etexilate Capsules

    Ruby Khatun Khatun11 July 2017 10:09 AM IST
    Vadodara: Alembic Pharmaceuticals Limited announced that the company has received tentative approval from the US Food & Drug Administration...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok